Ootaki Yoshio, Yamaguchi Masahiro, Yoshimura Naoki, Oka Shigeteru, Yoshida Masahiro, Hasegawa Tomomi
Department of Cardiothoracic Surgery, Kobe Children's Hospital, Hyogo, Japan.
J Thorac Cardiovasc Surg. 2004 Apr;127(4):953-8. doi: 10.1016/s0022-5223(03)01318-7.
Low-hematocrit bypass is one technique used to prevent allogeneic transfusion during cardiopulmonary bypass. The purpose of this study is to determine the efficacy of a criterion-driven transfusion protocol and the effect of low-hematocrit bypass with moderate hypothermia in pediatric cardiac surgery.
Seventy-five children who underwent cardiopulmonary bypass with low-hematocrit bypass for repair of congenital heart disease were studied. Criteria for red blood cell transfusion included anemia with a hematocrit level of less than 15% during bypass and 20% after bypass. During cardiopulmonary bypass, venous oxygen saturation, hematocrit values, and regional cerebral oxygenation were continuously monitored. Arterial lactate levels were measured postoperatively.
All patients had an uncomplicated perioperative course, and no perioperative death occurred. Twenty-two patients (29.3%) received a transfusion, and 53 (70.7%) patients did not. The hematocrit levels before and after modified ultrafiltration in the transfused group (21.6 +/- 5.5%, 26.6 +/- 6.5%) were significantly higher than those in the nontransfused group (18.9 +/- 3.7%, 23.1 +/- 4.1%) (P <.05). There was no significant difference between the group's arterial lactate levels immediately after admission to the intensive care unit and 1 day after the operation. The arterial lactate levels 6 hours after the admission to the intensive care unit for the nontransfused patients were higher than with the transfused patients (4.3 +/- 3.0 versus 2.5 +/- 1.5 mmol/L, (P <.05). For arterial lactate level, the relation with patients' weight had the highest correlation (R = 0.678, P <.0001).
A criterion-driven transfusion program can be effective, and low-hematocrit bypass with a hematocrit value below 20% may affect lactate production or clearance from the body.
低血细胞比容体外循环是一种用于预防体外循环期间异体输血的技术。本研究的目的是确定标准驱动输血方案的疗效以及在小儿心脏手术中采用中度低温的低血细胞比容体外循环的效果。
对75例接受低血细胞比容体外循环以修复先天性心脏病的儿童进行了研究。红细胞输血标准包括体外循环期间血细胞比容水平低于15%以及体外循环后低于20%的贫血情况。在体外循环期间,持续监测静脉血氧饱和度、血细胞比容值和局部脑氧合情况。术后测量动脉乳酸水平。
所有患者围手术期过程均无并发症,且未发生围手术期死亡。22例患者(29.3%)接受了输血,53例(70.7%)患者未输血。输血组改良超滤前后的血细胞比容水平(21.6±5.5%,26.6±6.5%)显著高于未输血组(18.9±3.7%,23.1±4.1%)(P<.05)。两组进入重症监护病房后即刻和术后1天的动脉乳酸水平无显著差异。未输血患者进入重症监护病房6小时后的动脉乳酸水平高于输血患者(4.3±3.0对2.5±1.5 mmol/L,P<.05)。对于动脉乳酸水平,与患者体重的相关性最高(R = 0.678,P<.0001)。
标准驱动的输血方案可能有效,血细胞比容值低于20%的低血细胞比容体外循环可能会影响乳酸的产生或从体内的清除。